XCL1 Pharmaceutical composition for prevention or treatment of muscular disease containing mesenchymal stem cells or XCL1

摘要

The present invention relates to a pharmaceutical composition for prevention or treatment of muscle diseases comprising mesenchymal stem cells or XCL1 protein or derivatives thereof, and a method for screening a therapeutic agent for muscle diseases. Since the mesenchymal stem cell or XCL1 protein of the present invention has an effect of inhibiting muscle cell or mycobacterial cell death, it can be effectively used for prevention or treatment of muscle diseases, and the cytotoxic inhibitor including XCL1 protein can be used for cell death Can be utilized.